Core Viewpoint - Elevance Health's shares experienced a 5.4% increase, closing at $452.69, driven by notable trading volume and a broader market shift towards defensive sectors like healthcare amid market volatility [1][2]. Group 1: Stock Performance - Elevance Health's stock gained 8% over the past four weeks, reflecting investor interest in stable investments during uncertain market conditions [1][2]. - The company's share price rise is attributed to a shift from tech and industrial stocks to healthcare, as investors seek stability [2]. Group 2: Financial Outlook - The upcoming quarterly earnings report is expected to show earnings of $10.92 per share, a year-over-year increase of 2.6%, with revenues projected at $45.94 billion, up 8.7% from the previous year [4]. - Despite the positive earnings and revenue growth expectations, the consensus EPS estimate has been revised 1.4% lower in the last 30 days, indicating potential caution among investors [5]. Group 3: Strategic Positioning - Elevance Health's strong position in managed care and stable revenue from government-backed programs enhances its appeal to risk-averse investors [2]. - The company is focusing on improving margins and operational efficiencies in Medicaid and Medicare Advantage plans, which is expected to strengthen its financial position [3].

U.S. health benefits company Elevance Health, Inc. (ELV) appears undervalued. It is currently trading at 12.25X forward 12-month earnings, below its five-year median of 13.44X and the industry average of 15.40X. It also trades at a discount to major health insurance companies like UnitedHealth Group Incorporated (UNH) and Humana Inc. (HUM) , which have forward P/E ratios of 16.46X and 16.86X, respectively. ELV currently holds a Value Score of A.This discounted valuation could reflect market skepticism about ...

We wrote about Elevance Health (NYSE: ELV ) in December of last year . Share prices were down approximately 30% after the Q3 results. The company had revised its short-term and long-term growth outlook. With theWe use Cash Flow Returns On Investment based DCF valuation tools provided by our affiliate company, ROCGA Research.With over 20 years of experience in investment analysis, we are actively seeking out undervalued and quality companies.ROCGA Research is an online platform that provides an objective and ...

Elevance Health (ELV) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.4% gain over the past four weeks.Elevance Health rallied for the sixth straight day, driven by optimism around its operations. The reaffirmed earnings forecast and medical enrollments boosted investor confidence, while multiple analyst updates with higher price targets added fuel to the momen ...

Group 1 - The article emphasizes a dividend-focused value investment strategy that prioritizes capital preservation and steady income growth [1] - The author discusses a diversified dividend stock portfolio that includes high-quality value stocks with potential for meaningful growth and long-term safety [1] Group 2 - The author has a beneficial long position in the shares of ELV, indicating a personal investment interest in the company [2] - The article is presented as a personal opinion and does not constitute professional investment or tax advice [3]

I only buy strong businesses. I only buy them when they're cheap. Backgrounds in economics, philosophy, government, data. I started my investing journey with a fairly concentrated portfolio of Canadian dividend payers in the telecom, pipeline and banking industries. I have moved forward through different industries including payments, US regional banking, Chinese and Brazilian equities, REITs, technology companies and a few other emerging market opportunities, as well as microcap through to megacap range. I ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-16751 ELEVANCE HEALTH, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...

Elevance Health, Inc. (ELV) reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.84, which surpassed the Zacks Consensus Estimate by 1.1%. However, the bottom line deteriorated 31.7% year over year.See the Zacks Earnings Calendar to stay ahead of market-making news.Operating revenues of $45 billion rose 6% year over year. Moreover, the top line beat the consensus mark by a whisker.Better-than-expected quarterly results benefited from rising premiums and product revenues. Rising expenses and ...

Financial Data and Key Metrics - The company will discuss its financial results and guidance for Q4 2024 and the outlook for 2025 [4] Business Line Data and Key Metrics - The company has multiple business lines including Government Health Benefits, Commercial Health Benefits, and Carelon, each led by respective presidents [3] Market Data and Key Metrics - No specific market data or key metrics mentioned in the provided content Company Strategy and Industry Competition - The CEO will review the progress made against the company's strategic initiatives and discuss the quarter and the 2025 outlook [4] Management Commentary on Operating Environment and Future Prospects - The CEO will provide insights into the company's strategic progress and future outlook during the call [4] Other Important Information - The conference call is being recorded, and participants are encouraged to present a single question during the Q&A session [2] Q&A Session Summary - No specific questions or answers were provided in the content for the Q&A session

Elevance Health 4Q 2024 Earnings Presentation January 23, 2025 The Value We Deliver We advance whole health through innovative solutions that integrate physical, behavioral, and social care to achieve our purpose of improving the health of humanity For Consumers Simple, Affordable, and Accessible Health Care For Care Providers Deepen Clinical and Business Partnerships 2 1. Simplifying healthcare through enhanced digital capabilities that personalize member experiences 2. Affordability at the core of our inn ...